This blended vial combines CJC-1295 (without DAC) and Ipamorelin in equimolar 5mg/5mg proportions, targeting two distinct pathways of growth hormone release simultaneously. CJC-1295 amplifies GH pulse amplitude via the GHRH receptor; Ipamorelin increases GH pulse frequency via GHSR-1a — producing 3–8× baseline GH elevation in published models.
- Dual-receptor synergy — simultaneous GHRH and ghrelin receptor activation produces additive GH release exceeding either agent alone.
- Amplified GH and IGF-1 — 3–8× baseline GH elevation and sustained IGF-1 upregulation.
- Physiological pulse preservation — preserves pulsatile GH secretion, reducing receptor desensitisation risk.
- Single-vial convenience — eliminates separate reconstitution and blending, ensuring consistent compound ratios.
- Sleep and recovery research — GH secretagogue combinations associated with increased slow-wave sleep in animal studies.
⚠️ For research use only. Not for human or animal consumption. Store at −20°C. Reconstitute with Bacteriostatic Water.
Reviews
There are no reviews yet.